Capricor Therapeutics Inc (CAPR)

[VMB-1]

~Actually was in the 8-K too: "But two patients are in critical condition as of May 4 and there is no assurance that those patients will ultimately survive.

The efficacy of CAP-1002 in treating COVID-19 was not necessarily demonstrated because the sample size was small, ***the six patients were contemporaneously on other experimental medications*****, and no control group was established. "